Literature DB >> 10568894

The American College of Rheumatology criteria for the classification of systemic lupus erythematosus: strengths, weaknesses, and opportunities for improvement.

E L Smith1, R H Shmerling.   

Abstract

The American College of Rheumatology classification criteria were developed to operationalize the definition of systemic lupus erythematosus (SLE) to allow comparison of clinical research from different centers, but also serve to facilitate education and to guide clinical practice. The classification criteria have been critical to research, but should be viewed as a temporary step until improved understanding of the pathogenesis of SLE emerges. Criteria have inherent limitations, including bias towards more severe and longer duration disease, equal weighting of features that vary in clinical significance, and exclusion of patients with SLE from research because they do not meet criteria. For some SLE research questions, it may be appropriate to include patients diagnosed with SLE who do not meet criteria, if these patients' manifestations and criteria are documented explicitly. SLE disease activity, cumulative organ damage, disease duration, criteria ever met, and criteria met at time of enrollment are important data that should be presented in clinical studies of SLE regardless of the number of criteria met. The criteria should be reevaluated periodically, utilizing patients and controls with a range of diseases and disease severity. A simplified weighting system may more accurately reflect clinical practice.

Entities:  

Mesh:

Year:  1999        PMID: 10568894     DOI: 10.1191/096120399680411317

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  35 in total

1.  Increased expression of Bruton's tyrosine kinase in peripheral blood is associated with lupus nephritis.

Authors:  Wei Kong; Wei Deng; Yue Sun; Saisai Huang; Zhuoya Zhang; Bingyu Shi; Weiwei Chen; Xiaojun Tang; Genhong Yao; Xuebing Feng; Lingyun Sun
Journal:  Clin Rheumatol       Date:  2017-06-14       Impact factor: 2.980

2.  Acyclovir-induced thrombocytopaenia in a patient with SLE.

Authors:  Irene Tsappa; Constantinos Missouris; Savvas Psarellis
Journal:  BMJ Case Rep       Date:  2018-06-08

3.  Histiocytic necrotising lymphadenitis identical to Kikuchi-Fujimoto disease in CNS lupus.

Authors:  Maria Ioanna Stefanou; German Ott; Ulf Ziemann; Annerose Mengel
Journal:  BMJ Case Rep       Date:  2018-06-08

4.  Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with systemic lupus erythematosus and good outcome with rituximab treatment.

Authors:  P G Sanz; C V García Méndez; A L Cueto; V B Silva; J C Walther; R A Diez; S Martins; R J Giannaula
Journal:  Rheumatol Int       Date:  2011-09-16       Impact factor: 2.631

5.  Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy.

Authors:  Fei Gu; Dandan Wang; Huayong Zhang; Xuebing Feng; Gary S Gilkeson; Songtao Shi; Lingyun Sun
Journal:  Clin Rheumatol       Date:  2014-08-14       Impact factor: 2.980

6.  Expression of Toll‑like receptors 3 and 9 in Egyptian systemic lupus erythematosus patients.

Authors:  A S Nasr; S M Fawzy; T A Gheita; E El-Khateeb
Journal:  Z Rheumatol       Date:  2016-06       Impact factor: 1.372

7.  Distribution of human leukocyte antigen alleles in systemic lupus erythematosus patients with angiotensin converting enzyme insertion/deletion polymorphism.

Authors:  Nageen Hussain; Ghazala Jaffery
Journal:  Bosn J Basic Med Sci       Date:  2013-02       Impact factor: 3.363

8.  Involvement of TWEAK and the NF-κB signaling pathway in lupus nephritis.

Authors:  Fang Sun; Jian Teng; Pengfei Yu; Wenshuang Li; Jing Chang; Honglei Xu
Journal:  Exp Ther Med       Date:  2018-01-05       Impact factor: 2.447

9.  Haem oxygenase 1 expression is altered in monocytes from patients with systemic lupus erythematosus.

Authors:  Andrés A Herrada; Carolina Llanos; Juan P Mackern-Oberti; Leandro J Carreño; Carla Henriquez; Roberto S Gómez; Miguel A Gutierrez; Ignacio Anegon; Sergio H Jacobelli; Alexis M Kalergis
Journal:  Immunology       Date:  2012-08       Impact factor: 7.397

10.  Expression of HMGB1 and TLR4 in neuropsychiatric systemic lupus erythematosus patients with seizure disorders.

Authors:  Qin Huang; Shuqun Shen; Hang Qu; Yu Huang; Danni Wu; Haishan Jiang; Chao Yuan
Journal:  Ann Transl Med       Date:  2020-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.